[中报]稳健医疗(300888):2022年半年度报告(英文版)

时间:2022年09月30日 18:47:49 中财网

原标题:稳健医疗:2022年半年度报告(英文版)

Section I Important Notes, Contents, and Definitions
The Board of Directors, the Board of Supervisors and directors, supervisors and senior management of Winner Medical hereby guarantee that the statement in this Semi-annual Report is authentric, accurate and complete without false or misleading information or material omission and will assume all the legal liabilities, individually and jointly.
Li Jianquan, the head of the Company, Fang Xiuyuan, the accounting head, and Wu Kezhen, the head of accounting body (accounting manager), guarantee the authenticity, accuracy, and completeness of the financial report in this semi-annual report.
All directors of the Company personally attended the board meeting for reviewing this report.
The forward-looking contents in this report, such as the future development strategy and performance planning, are the goals sets by the Company, which are planned matters. The achievement of the goals depends on many factors, including market change, which is uncertain. So these contents are not the company's profit forecast for the next year and do not constitute a substantial commitment of the Company to investors and related parties. Investors and related parties should be fully aware of related risks and understand the differences among plans, forecasts, and commitments. Investors are asked to beware of investment risks!
The Company does not plan to distribute cash dividends, issue bonus share, or increase the share capital from reserves.

Table of Contents
Section I Important Notes, Contents, and Definitions ............................................................. 2
Section II Company Profile and Major Financial Indicators ................................................. 7
Section III Management Discussion and Analysis ................................................................. 10
Section IV Corporate governance ........................................................................................... 51
Section V Environment and Social Responsibility ................................................................. 53
Section VI Important Matters ................................................................................................. 60
Section VII Changes in Shares and Shareholders.................................................................. 66
Section VIII Preferred Shares ................................................................................................. 72
Section IX Information Related to Bonds ............................................................................... 73
Section X Financial Report ...................................................................................................... 74

Document Catalog
(I) Financial statements containing the signatures and seals of the person in charge of the Company, the accounting head, and the
person in charge of the accounting body (accounting manager). (II) The originals of all company documents and announcements publicly disclosed during the reporting period.


  Definitions
TermRefers toDefinition
Company, Winner MedicalRefers toWinner Medical Co., Ltd.
Winner GroupRefers toWinner Group Limited, a controlling shareholder of the Company
Sequoia XinyuanRefers toBeijing Sequoia Xinyuan Equity Investment Center (L.P.), a shareholder of the Company before the initial public offering
Xiamen LeyuanRefers toXiamen Leyuan Investment Partnership (L.P.), a shareholder of the Company before the initial public offering
Xiamen YutongRefers toXiamen Yutong Investment Partnership (L.P.), a shareholder of the Company before the initial public offering
SCGCRefers toShenzhen Capital Group Co., Ltd., a shareholder of the Company before the initial public offering
Xiamen HuikangRefers toXiamen Huikang Investment Partnership (L.P.), a shareholder of the Company before the initial public offering
Xiamen ZepengRefers toXiamen Zepeng Investment Partnership (L.P.), a shareholder of the Company before the initial public offering
Winner Medical (Chongyang)Refers toWinner Medical (Chongyang) Co., Ltd., a wholly-owned subsidiary of the Company
Winner Medical (Jiayu)Refers toWinner Medical (Jiayu) Co., Ltd., a wholly-owned subsidiary of the Company
Winner Medical (Jingmen)Refers toWinner Medical (Jingmen) Co., Ltd., a wholly-owned subsidiary of the Company
Winner Medical (Yichang)Refers toYichang Winner Medical Textile Co., Ltd., a wholly-owned subsidiary of the Company
Winner Medical (Huanggang)Refers toWinner Medical (Huanggang) Co., Ltd., a wholly-owned subsidiary of the Company
Winner Medical (Tianmen)Refers toWinner Medical (Tianmen) Co., Ltd., a wholly-owned subsidiary of the Company
Shenzhen PurcottonRefers toShenzhen Purcotton Technology Co., Ltd., a wholly-owned subsidiary of the Company
Guangzhou PurcottonRefers toGuangzhou Purcotton Medical Technology Co., Ltd., a wholly-owned subsidiary of Shenzhen Purcotton
Beijing PurcottonRefers toBeijing Purcotton Technology Co., Ltd., a wholly-owned subsidiary of Shenzhen Purcotton
Shanghai PurcottonRefers toShanghai Purcotton Technology Co., Ltd., a wholly-owned subsidiary of Shenzhen Purcotton
Qianhai PurcottonRefers toShenzhen Qianhai Purcotton E-Commerce Co., Ltd., a wholly-owned subsidiary of Shenzhen Purcotton
PurunderwearRefers toShenzhen Purunderwear Sci-Tech Innovation Co., Ltd., a wholly-owned subsidiary of Shenzhen Purcotton
Winner (Huanggang) CottonRefers toWinner (Huanggang) Cotton Processing & Trading Co., Ltd., a wholly- owned subsidiary of Winner Medical (Huanggang)
Huanggang PurcottonRefers toHuanggang Purcotton Technology Co., Ltd., a wholly-owned subsidiary of Purcotton
Winner Medical MalaysiaRefers toWinner Medical Malaysia Sdn. Bhd., a subsidiary controlled by the Company
Winner Medical (Hong Kong)Refers toWinner Medical (Hong Kong) Ltd., a subsidiary controlled by the Company
Winner Medical (Heyuan)Refers toWinner Medical (Heyuan) Co., Ltd., a wholly-owned subsidiary of the Company
Winner Medical (Wuhan)Refers toWinner Medical (Wuhan) Co., Ltd., a wholly-owned subsidiary of the
   
  Company
PureH2BRefers toShenzhen PureH2B Technology Co., Ltd., a wholly-owned subsidiary of the Company
Chengdu Wenjian LikangRefers toChengdu Wenjian Likang Medical Products Co., Ltd., a wholly-owned subsidiary of the Company
Galaxy Real EstateRefers toShenzhen Galaxy Real Estate Development Co., Ltd.
Reporting periodRefers toJanuary 01, 2022 to June 30, 2022
Longterm MedicalRefers toZhejiang Longterm Medical Technology Co., Ltd., an enterprise with 55% equity acquired by the Company
Pingan Medical DeviceRefers toWinner Pingan Medical (Hunan) Co., Ltd., formerly known as Hunan Pingan Medical Device Technology Co., Ltd., an enterprise with 68.70% equity acquired by the Company
Guilin LatexRefers toWinner (Guilin) Latex Products Co., Ltd., formerly known as "Guilin Zizhu Latex Products Co., Ltd.", an enterprise with 100.00% equity acquired by the Company

Section II Company Profile and Major Financial Indicators
I. Company Profile

Stock abbreviationWinner MedicalStock code300888
Stock exchangeShenzhen Stock Exchange  
Company name in ChineseWinner Medical Co., Ltd.  
Chinese abbreviation of the company (if any)Winner Medical  
Company name in foreign language (if any)Winner Medical Co., Ltd.  
Company short name in foreign language (if any)Winner Medical  
Legal representative of the companyLi Jianquan  
II. Contact Person and Contact Information

 Secretary to the board of directorsSecurities affairs representative
NameChen HuixuanLiu Yanxiang, Zhang Heng
Contact addressF42, Building 2, Huilong Business Center, Shenzhen North Railway Station Area, Minzhi Subdistrict, Longhua District, ShenzhenF42, Building 2, Huilong Business Center, Shenzhen North Railway Station Area, Minzhi Subdistrict, Longhua District, Shenzhen
Tel0755-280668580755-28066858
Fax0755-281346880755-28134688
Email[email protected][email protected]
III. Other Information
1. Contact information
Whether the Company's registered address, office address and postal code, company website and email were changed during the
reporting period
□ Applicable ? Not applicable
There is no change in the Company's registered address, office address and postal code, company website and email during the
reporting period, as shown in 2021 annual report.
2. Information disclosure and keeping place
Whether information disclosure and the place where the semi-annual report is kept were changed during the reporting period
□ Applicable ? Not applicable
The newspapers selected by the Company for information disclosure, the websites designated by the China Securities Regulatory
Commission (CSRC) for publishing the semi-annual report, and the place where the semi-annual report is kept were not changed
during the reporting period. See the 2021 Annual Report for details. 3. Change of registration
Whether the registration status was changed during the reporting period □ Applicable ? Not applicable
There were no changes in the Company's registration during the reporting period. See the 2021 Annual Report for details.
IV. Major Accounting Data and Financial Indicators
Whether the Company needs to retroactively adjust or restate the accounting data of the previous years
□Yes ?No

 Current reporting periodSame period last yearIncrease/decrease in this reporting period compared with the same period of the previous year
Operating income (yuan)Note1 5,157,944,495.724,059,865,654.9227.05%
Net profits attributable to shareholders of listed companies (yuan)892,823,503.14761,038,730.2417.32%
Net profits attributable to shareholders of the listed company after deduction of non-recurring profits and losses (yuan)820,558,767.23627,255,609.1930.82%
Net cash flow from operating activities (yuan)801,150,899.38197,604,865.77Note2 305.43%
Basic EPS (yuan/share)2.11931.784418.77%
Diluted EPS (yuan/share)2.11931.771519.63%
Weighted average return on net assets8.17%7.06%1.11%
 End of the reporting periodEnd of the previous yearIncrease/decrease at the end of the reporting period compared to the end of the previous year
Total assets (yuan)15,522,494,964.5113,266,610,200.3717.00%
Net assets attributable to shareholders of listed companies (yuan)10,991,151,831.9710,674,912,166.802.96%
Note 1: The income in the reporting period includes the consolidated operating income of Longterm Medical from May to June, which
is the newly acquired business of RMB 86,191,200 and the purchase date of Longterm Medical is April 30, 2022;
Note 2: During the reporting period, the net cash flow from operating activities increased by 305.43% compared with last year, which
was mainly due to the fact that: (1) in 2020, the Company applied a credit policy of 100% advance payment for the protective products,
and in the first half of 2021, the Company's credit policy for protective products has returned to the normal level; (2) the good
performance in 2020 has resulted in more taxes and fees paid after the final settlement in the first half of 2021.
V. Differences in Accounting Data under Domestic and Foreign Accounting Standards 1. Differences between net profits and net assets in financial statements disclosed according to the
International Accounting Standards (IAS) and Chinese Accounting Standards simultaneously □ Applicable ? Not applicable
No difference between net profits and net assets in financial statements disclosed according to the International Accounting
Standards (IAS) and Chinese Accounting Standards during the reporting period. 2. Difference between net profits and net assets in financial statements disclosed according to the Foreign
Accounting Standards and Chinese Accounting Standards simultaneously □ Applicable ? Not applicable
No difference between net profits and net assets in financial statements disclosed according to the Overseas Accounting Standards
and Chinese Accounting Standards during the reporting period. VI. Non-recurring Profit and Loss Items and Amount
?Applicable □ Not applicable
Unit: yuan

ItemAmountDescription
Profits and losses on the disposal of non-current assets (including the write-off part of the provision for asset impairment)(2,401,700.24) 
Government subsidies included into current profits and losses, except the government subsidies which are closely related to the normal business operations of the Company and conform to the national policies and regulations, and28,755,938.72 
continuously granted in accordance with a certain standard quota or amount.  
In addition to the effective hedging business related to the Company's normal business operations, the profit and loss from fair value changes arising from holding trading financial assets and trading financial liabilities, as well as the investment income from disposal of trading financial assets, trading financial liabilities and available-for-sale financial assets64,226,078.84 
Income and expenditure other than those mentioned above(4,634,764.37) 
Less: Amount affected by income tax13,612,940.25 
Amount of minority shareholders' equity affected (after tax)67,876.79 
Total72,264,735.91 
Other profit and loss items that are consistent with the definition of non-recurring profit and loss:
□ Applicable ? Not applicable
There was no other profit and loss items that are consistent with the definition of non-recurring profit and loss.
Explanation on defining the non-recurring profit and loss items enumerated in the Interpretative Announcement No. 1 on Information
Disclosure of Public Securities Issuing Companies - Non-recurring Profits and Losses as recurring profit and loss items
□ Applicable ? Not applicable
There was no circumstance in which non-recurring profit and loss items enumerated in the Interpretative Announcement No. 1 on
Information Disclosure of Public Securities Issuing Companies - Non-recurring Profits and Losses are defined as non-recurring
profit and loss items.

Section III Management Discussion and Analysis I. Main Business of the Company during Reporting Period The Company needs to comply with the disclosure requirements of the "Medical Device Business" stipulated in the No. 4 Guideline of Shenzhen Stock Exchange for Self-regulatory of Listed Companies - Information Disclosure by Growth Enterprises: The Company needs to comply with the disclosure requirements of the "Textile and Apparel Business" stipulated in the No. 3 Guideline of Shenzhen Stock Exchange for Self-regulatory of Listed Companies - Industry Information Disclosure. (I) Main Business of the Company during Reporting Period Winner Medical is a health enterprise developing both medical and consumption products under its three brands of "Winner", "Purcotton" and "PureH2B". Specifically, the Company has been adhering to the core business principle of "Quality before profit, brand before speed, social value before corporate value". Through continuous innovation and expansion of industrial boundaries, the Company has developed from a single manufacturer of medical consumables into a large medical health enterprise covering wound care, infection prevention, personal care, home care, maternal and child care, home textile and clothing and other fields. Wound care Infection protection Medical Disinfection and cleaning Winner Non-woven consumer Cotton tissues, sanitary pads, wet tissues goods Textile consumer goods Baby supplies, baby clothing, adult clothing Consumables Beauty products and perfumes Health & personal care Home sports 1. Medical consumables section Winner Medical is a benchmarking enterprise in the domestic medical consumables industry. Its main product lines cover wound care, infection prevention and disinfection and cleaning. The specific products include high-end wound dressing products, traditional wound care and dressing products, infection control products in operating room, protective products and disinfection and cleaning products for body surface cleaning.
The Company is one of the earliest medical consumables enterprises in China to establish a full industrial chain covering cotton
procurement, R&D, production and direct export. The Company's products have been certified by the EU CE certification, the US FDA
certification and the Japanese Ministry of Health, Labour and Welfare certification, and exported to Europe, America, Japan and other
countries. In 2005, "Winner" brand entered the domestic hospital and drugstore market. With its excellent product quality and service,
Winner Medical gradually established a good brand and reputation in domestic hospitals and drugstores. Since the outbreak of COVID-
19 in 2020, the "Winner" brand prevention products have entered the hospital and the civilian market. Thanks to the public commitment not to increase prices and the quality of its products, it has won the unanimous praise at home and abroad, from government units and the public, and the brand reputation and popularity have been greatly improved. In terms of products, Winner Medical focuses on market demand, is close to clinical and terminal, is driven by R&D and innovation, and constantly improves product layout. Its business scope extends from sales of single wound care products such as cotton gauze to sales of comprehensive solutions of wound care, infection prevention, disinfection and cleaning. Disposable operating room consumables can more effectively reduce nosocomial infection than reusable medical products. With more attention of the state and hospitals to nosocomial infection and residents' attention to personal health environment, disposable operating room consumables are gradually accepted by the domestic market. Winner Medical's medical dressing product line has been expanded from traditional dressing products mainly focusing on gauze products to high-end wound dressing products, such as silica gel foam dressing, hydrocolloid dressing, super absorbent pad, negative pressure drainage products, etc., which are mainly applied to chronic wound healing scenes such as diabetes, large-area burns and wounds. The Company's technical level in the field of high-end wound dressings has been in the forefront of the industry, and is expected to become the core products for the development of Winner Medical.
2. Healthy Consumer Goods Section
Purcotton is a healthy life brand with "Medical background, Purcotton philosophy, Quality in our DNA" as its core competitiveness,
which starts with pure cotton spunlace non-woven fabric and takes "medicine close to life, Purcotton care for health" as its brand
proposition. Its products include pure cotton tissue, sanitary pads with pure cotton surface, pure cotton wet tissues and other non-woven
consumer goods, as well as baby supplies, baby clothing, baby products, adult clothing and other textile consumer goods. Purcotton
advocates the life concept of "comfort, health, environmental protection", replacing chemical fiber with cotton and keeping away from
chemical stimulation. It provides overall solutions for different life scenes, having a good user reputation and formed a fully
differentiated brand image in the field of consumer goods with strong brand appeal. In terms of products, with excellent quality control ability and technology research and development ability, the Company continues to introduce medical grade quality consumer goods. Cotton is the main raw material of core products of Purcotton, which adopts global high-quality cotton to control product quality and safety from the source. According to the high standard of medical consumables, all kinds of pollution sources are strictly controlled in the production process. Disposable underwear, newborn baby clothes and other close-fitting clothing are packaged with medical grade sterilization to further ensure the safety and environmental protection of the products. Purcotton products cover multiple consumer groups, such as mothers and infants, children and adults, and span multiple product lines, such as high-end cotton wipes, female care, baby care, adult clothing, home textile products, etc. In July 2019, the Company launched the "PureH2B" brand, aiming to build a one-stop retail platform covering beauty makeup, personal
care, sports and other healthy and beautiful life needs. "PureH2B" has sold products through offline stores, online official website and
Wechat mini programs, and its business is still at the initial stage.
(II) Main Products and Purposes
Its health product system covers: wound care products, infection prevention products, disinfection & cleaning products under its
medical consumables section; the non-woven consumer goods and textile consumer goods under its healthy consumer goods section;
and pure cotton spunlace non-woven fabric, an industry intermediate product. The main categories and images of some products under the Company's medical consumables section are as follows:

Product ClassProduct CategoryMain PurposeProductImage of Some Products
Wound care productsTraditional wound care productsFor absorbing wound exudate, dressing wounds, and sports protectionGauze sheets, non-woven sheets, gauze bandage, dressing change kits, etc. 
 Advanced wound care productsFor creating a moisture balance at the wound interface to optimize its benefits for wound healing, reduce the frequency of dressing replacement, and reduce secondary damageSilicone dressings, alginate dressings, etc. 
Infection prevention productsOR infection control productsFor preventing infections in the operating roomSurgical packs, surgical gowns, etc. 
 Disease prevention and control productsFor occupational protection of medical staff and patient isolationMasks, protective clothing, isolation gowns, gloves, foot straps, hats, etc. 
Disinfecti on & cleaning productsDisinfection & cleaning productsFor wound cleaning and disinfection, and daily cleaningCotton swabs, cotton pads, cotton balls, alcohol cotton pads, disinfectant, etc. 
As the important guarantee for medical staff's occupational protection and patient isolation protection, disease protection and control
products such as masks and protective clothing play an indispensable role in coping with major health incidents and improving public
health. The main categories and images of some products under the company's healthy consumer goods section are as follows:

ClassProduct CategoryProductImage of Some Products
Non- woven consumer goodsCotton tissues  
 Wet wipes  
 Sanitary pads  
 Other non-woven consumer goodsCotton swabs, makeup cotton pads, disposable underwear, etc. 
Textile consumer goodsBaby suppliesBaby's bath towels, handkerchiefs, and quilts, etc. 
 Baby clothingBaby's leisure wear, outing costume, underwear, footwear, etc. 
 Adult clothingAdult's leisure wear, outing costume, underwear, footwear, etc. 
 Other textile consumer goodsBedding, bathroom accessories, etc. 
The purposes and images of the Company's pure cotton spunlace nonwoven fabric are as follow:
ClassMain PurposeImage
Cotton spun lace non- woven fabricWith 100% quality cotton as raw materials, the fabric is made with the pure cotton spunlace non-woven fabric technology. It can be used in fields such as personal care, home care, medical equipment, and industrial wipes. 
(III) Main Operating Modes
1. Procurement mode
The Company has established a complete procurement management system, which mainly includes the Procurement Control Process,
Procurement Price Management Process, New Supplier Selection and Review Control Process, Supplier Performance Appraisal
purchase applications shall be submitted by requiring departments based on customer orders, sales plans, and production plans. The purchasing department shall strictly follow the purchasing management regulations after analyzing the purchasing requirements and the raw material market. The procurement of key bulk raw materials (such as cotton and cotton yar) is implemented in a unified manner according to the Company's rules on its strategic procurement. The Company implements a strict supplier management system to ensure product quality and stable product supply. The Company has set a supplier directory and a perfect update and elimination mechanism to dynamically manage existing suppliers and new suppliers, which enables the Company to preferentially cooperate with the suppliers with the highest assessment results. For new suppliers, the Company has made strict selection criteria and supplier development and process management systems, including on-site inspection on suppliers; for suppliers with poor or even unqualified annual performance, the Company will add them to the key watch list or eliminate them. Generally, the Company will sign an annual framework agreement with a supplier to specify the cooperation content and the annual cooperation arrangement, and specific procurement contracts will be signed separately. 2. Production mode The Company formulates production plans according to customers' POs and requirements, its annual sales plans, and monthly rolling sales plans. Based on its own production capacity and demand fluctuations, the Company adopts the production strategies of Make to Order (MTO) and Made to Stock (MTS). 3. Sales mode The Company sells products through multiple channels. The main sales channels are shown in the following figure: 4. Marketing mode
The Company is developing its products under the Winner, Purcotton, and PureH2B brands a coordinated way. With more than 30
years of experience in the production of medical supplies, Winner is a leading medical consumables brand in the Chinese market and
with a global vision. With "caring for health and life, making a better world" as its vision and industry-leading product quality as the
cornerstone of its brand value, the product marketing and promotion for the brand rely more on its brand reputation. With pure cotton
products as its label, Purcotton ad opts unique, differentiated strategies to build its brand. By integrating multiple promotion channels
such as directly-operated stores, brand roadshows, celebrity endorsements, event sponsorship, new media, and advertising, Purcotton
keeps conveying to consumers its proposition of "medicine close to life, Purcotton care for health" and its vision of "changing the
world with pure cotton", which helps deepen the meaning of Purcotton brand and increase its brand awareness and loyalty. PureH2B
offers consumers selected products that are high-quality, healthy, and beautiful from around the world through its paid membership
system. It offers its members products with extremely competitive prices and a series of excellent offline services such as beauty salons,
free makeup, and seminars. With "Love, protect and enjoy nature" as its brand vision, and "Influence the mainstream consumption
attitude with the philosophy of 'inner health brings outer beauty', and attract mainstream consumers with natural products" as its mission,
PureH2B is bringing consumers a new all-round digital retail experience. (IV) Main Driving Factors of Performance
1. Medical consumables industry and consumer goods industry will keep growing rapidly As the global demand for healthcare of aging population increases, resident income continues to grow, and medical and healthcare
improve, the global medical consumables market is showing a steady growth trend. The COVID-19 pandemic has made global
consumers pay more attention to health and personal protection. In China, especially, most families choose to wear masks when they
take public transport and are in public places, so the demand for masks is expected to increase significantly compared with that before
the COVID-19 pandemic. After the COVID-19 pandemic outbreak, as the government, medical workers, and consumers in China pay
greater attention to protection and quality, the use rate of disposable medical consumables and disposable surgical packs will get higher;
on the other hand, as the Chinese government attaches importance to the medical consumables industry, the supervision over the
industry are continuously strengthened while the reserves of medical consumables are increasing. Therefore, companies that do not
comply with laws and regulations will surely be eliminated. In addition, China's medical dressings are changing from traditional
dressings to high-end wound dressings, and it is expected to replace imported dressings by domestic dressings step by step. The medical
consumables market in China is growing rapidly, creating a good external environment for enterprise development.
In recent years, the total retail sales of consumer goods in China has been rising steadily, showing an obvious trend of consumption
upgrading. Consumers' demand for green, healthy, and environmentally friendly products is increasing, bringing good opportunities in
the consumer goods industry.
2. High-quality products and precise brand positioning enhance brand value The Company is one of the earliest medical consumables enterprises in China to establish a full industrial chain covering cotton
procurement, R&D, production, and direct export. The Company is one of the early companies that established a medical-grade quality
management system in the industry, and has passed the ISO13485 Medical Devices Quality Management System Certification. Its
product quality complies with the European, American, Japanese, and Chinese standards. Winner Medical enjoys a high brand
reputation and recognition. In 2020, Winner Medical was praised by the Joint Prevention and Control Mechanism of the State Council
as a well-deserved "ordnance factory" in fighting the pandemic. Its wholly-owned subsidiary Winner Medical (Huanggang) was
awarded the title of "National Advanced Unit for Fighting the COVID-19 Pandemic" by the CPC Central Committee and the State
Council. It is also the only enterprise awarded the title in Hubei Province. In May 2021, Winner Medical was selected by the Federation
of Shenzhen Industries as the "Benchmarking Enterprise in China's Medical Consumables Sector" and at the same time recognized as
an "International Renowned Brand" by the United Nations Industrial Development Organization. In December 2021, "pure cotton
spunlace non-woven fabrics and its products" of Winner Medical was awarded as the national single champion of manufacturing
industry. In 2022, the epidemic prevention department of the Company was successively awarded the title of "Worker Pioneer" by All
China Federation of Trade Unions and Shenzhen Federation of Trade Unions. Purcotton is committed to fulfilling consumers' upgrading demand for high-quality products which are "comfortable, healthy, and
environmentally friendly". With constantly winning recognition from consumers since its launch in 2009, Purcotton has rapidly grown
into a leading brand of maternal and child products on e-commerce platform, and has a high market share in the field of consumer
products. In October 2019, Purcotton won the reputation of "70 Brand of the 70th Anniversary of the Founding of New China"
sponsored by CCTV. In January 2021, Purcotton was honored as one of the "Shenzhen Top Brands" by Federation of Shenzhen
Industries. In April 2021, Purcotton was included into the list of the second "Shenzhen Top 100 Brands" announced by Shenzhen
Quality City Promotion Association.
In conclusion, with high brand value, the Winner Medical and Purcotton brands will help the Company enhance customer loyalty,
stabilize product prices, and expand its market share in the competitive market, thereby ensuring its sustainable and stable profitability.
II. Analysis of Core Competitiveness
1. Advantages of business philosophy and corporate culture
With offering quality products as its mission, the Winner Medical brand aims to lead in the medical dressing industry, to grow from a
small Chinese enterprise offering lower-price products to a large international enterprise offering high-quality products recognized by
developed countries, bringing Chinese medical dressings to the international stage. With "caring for health and life, making a better
world" as its vision, the brand keeps focusing on product quantity and innovations, and making its way into the medical consumables
and high-end medical dressing market. Cotton fiber has ten prominent advantages, including natural, safe, comfortable, naturally
degradable, high output ratio, drought-resistant, salt and alkali-resistant, environmentally friendly, time-honored, as well as great
economic and social value. With its corporate vision of "changing the world with pure cotton", Purcotton advocates a lifestyle with
pure cotton by applying "comfortable, healthy, and environmentally friendly" in all aspects of daily life, to help customers raise life
quality, and deliver the brand concept of "reassurance, happiness and sustainability" to consumers. Sticking to the "cotton fiber only"
principle in its operation, Purcotton aims to develop recyclable and renewable resources, gradually replace chemical fibers with natural
fibers, and give full play to the use value and environmental protection value of cotton fibers, following the path of low carbon,
environmental friendly and sustainable development. With "love nature, protect nature, enjoy nature" as its brand vision, PureH2B
insists on the principle of pursuing beauty without sacrificing health for health is beauty. PureH2B select natural cosmetics and toiletries,
healthy food and health products, 3C and health equipment with excellent experience from around the world for customers. Meanwhile,
the groundbreaking, innovative natural products developed independently by PureH2B are winning the trust of consumers with their
applicability and safety, meeting the needs of consumers who pursue both quality life and health and environmental protection. The
visions and business philosophies regarding the company's three brands are focused on human health, environmental protection, and
improving the quality of life, which are in line with humans' sustainable development strategy. The Company will always uphold its core operating principle of "prioritizing quality over profit, brand over speed, and social
responsibility over corporate value", and stick by its core values of "others first, responsibility, unity and cooperation, hard work, self-
criticism, and sustainable development". The Company promotes healthy sports such as running, mountain climbing, and ball games.
The Company is weakening the power from titles to reduce bureaucracy, and creating open workplaces to ensure efficient cross-
department communication. During the epidemic, the Company responded quickly and made every effort to ensure the production of
protective products. It carried out a series of activities to improve the rapid response capability to market demand in terms of decision-
making management, process integration, product and equipment innovation, and industry chain integration. Within one month at the
beginning of the epidemic outbreak in January 2020, the Company provided 108.9 million masks and 114,000 pieces of protective
clothing to major hospitals in Hubei, showing the Company's efficient internal coordination capability.
2. Advantages of R&D and innovation
The Company independently developed the pure cotton spunlace non-woven technology in 2005, and has built a complete technology
cluster based on the technology, obtaining patent licenses in more than 30 countries and regions including the United States, Europe,
and Japan. The silica gel foam dressing and foam dressings successfully developed and launched by the Company have been awarded
with China's registration certificate for Class II and Class III medical devices respectively. This kind of high-end wet wound dressing
is specially designed for the vulnerable skin of the elderly with chronic diseases, facilitates the observation of wound healing by medical
staff, and also provides patients with a cost-effective solution for chronic wound treatment, effectively solving the clinical pain points
such as the adhesion of traditional gauze dressings to wounds and frequent dressing changes. The innovative application of pure cotton
spunlace non-woven fabrics in infection prevention products, such as protective clothing, surgical gowns, and isolation gowns, has not
only alleviated the shortage of raw materials during the pandemic but also improved the breathability and comfort of anti-pandemic
products, which is safe and environmentally friendly. In the field of consumer products, the Company has developed pure cotton tissues,
pure cotton wet tissues, sanitary pads with pure cotton surface, as well as disposal cleansing towels, disposable underwear and other
products. It has been invited to participate in the development of a number of national standards and industry standards, drafting and
developing performance requirements for pure cotton non-woven surgical dressings, and technical specifications for contact trauma
dressings and children's masks. As the first and major drafter, Purcotton, a wholly-owned subsidiary of the Company, led the
development of national standards for cotton tissues (GB/T 40276-2021), which requires that the fiber composition and content of
cotton tissues shall be identified, and the fiber content tolerance shall comply with the provisions of GB/T 29862 (implemented on
December 1, 2021). In December 2021, "pure cotton spunlace non-woven fabrics and its products" of the Company was awarded as
the national single champion of manufacturing industry.
Since its establishment, the Company has been attaching great importance to scientific and technological innovation and cooperation. (未完)
各版头条